Clinical Trials List
2025-11-20 - 2035-06-30
Others
Recruiting3
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林明泰 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
- 張時榮 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高冠鈞 Division of Hematology & Oncology
- Shang-Fu Hsu Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
450 participants
